Cellarity key facts
as of Oct 2026- Developer of a biomedical platform designed to digitize the molecular information in cells to elucidate how they behave in health and disease.
- Cellarity is valued at approximately $525.0M as of Oct 2026 (last reported valuation).
- It has raised $519.3M; the latest was Later Stage VC ($195.0M) in Dec 2024.
- Notable investors include BlackRock, Flagship Pioneering, Pictet, Hanwha Impact, The Baupost Group — 9 tracked in total.
- Status: Privately Held (backing).
Cellarity's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·Watch Cellarity: the Monday email on marks, rounds and moves
Cellarity funding rounds
No funding rounds for Cellarity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Cellarity valuation
Cellarity's last reported valuation was $525 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Cellarity investors
9 investors are on record for Cellarity, including BlackRock, Flagship Pioneering, Pictet and Hanwha Impact.
About Cellarity
Developer of a biomedical platform designed to digitize the molecular information in cells to elucidate how they behave in health and disease. The company's platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them, enabling companies to increase drug discovery's success rate and speed.
- Sector
- Healthcare
- HQ
- Somerville, MA, United States
- Founded
- 2019
- Employees
- 88
- Website
- cellarity.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.